Targeted Delivery of Doxorubicin Liposomes for Her-2+ Breast Cancer Treatment.

Chowdhury N, Chaudhry S, Hall N, Olverson G, Zhang QJ, Mandal T, Dash S, Kundu A. Targeted Delivery of Doxorubicin Liposomes for Her-2+ Breast Cancer Treatment. AAPS PharmSciTech. 2020 Jul 21; 21(6):202.

View in: PubMed

subject areas

Animals
Antibiotics, Antineoplastic
Breast Neoplasms
Cell Line, Tumor
Doxorubicin
Drug Delivery Systems
Female
Humans
Liposomes
Nanoparticles
Polyethylene Glycols
Receptor, erbB-2

authors with profiles

Tarun Mandal
Qian-Jin Zhang

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support